, , , ,

In the USA (see stories below), a battle is raging about the sale of genetically modified salmon grown with technology developed in labs on Prince Edward Island.

Food safety and environmental organizations are pushing retail giant Costco to refuse to stock a brand of genetically engineered salmon awaiting approval by the Food and Drug Administration.

Target, Kroger, Safeway, Trader Joe’s and other companies have already committed to refrain from selling the salmon, dubbed “Frankenfish” by opponents of food made with genetically modifies organisms (GMOs).

The Center for Food Safety, along with the groups Friends of the Earth, Food & Water Watch and Consumers Union, are gathering signatures in support of a letter to Costco CEO Craig Jelinek, urging him to follow suit.

A news release from AquaBounty appearing in the business press paints a different story:

StockMarketWire.com – AquaBounty Technologies – a biotechnology company focused on enhancing productivity in the aquaculture market – posts net losses of $4.7m for the year to the end of December, up from $4.4m last time.
Operating spend was higher at US$4.9m (2012: US$4.4m) as the company invested in new research projects.

Chief executive Ron Stotish said: “We are pleased that the company achieved two significant milestones in the year: firstly, the US Food and Drug Administration completed the public comment period on its draft Environmental Assessment and preliminary Finding of No Significant Impact for AquAdvantage® Salmon; and secondly, Environment Canada decided that AAS is not harmful to the environment or human health when produced in contained facilities.

“While we cannot be certain about the timing, the Board is working on the assumption that approval will be forthcoming in 2014. The strong support provided by Intrexon provides the Company with sufficient financial resources to fund our operations through mid-2015 and carry out appropriate preparations for commercial development once AAS receives approval.”